Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Plos One|June 2, 2021
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor RegistryFernando Franco, Enric Carcereny, Maria Guirado, et al.
JAMA Oncology|December 15, 2022
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled TrialMariano Provencio, Ana Laura Ortega, Juan Coves-Sarto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 TrialDaniel S W Tan, Enriqueta Felip, Gilberto de Castro, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2024
Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registryMariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, et al.
ESMO Open|November 20, 2020
Lung cancer symptoms at diagnosis: results of a nationwide registry studyAlberto Ruano-Raviña, Mariano Provencio, Virginia Calvo de Juan, et al.
The New England Journal of Medicine|September 29, 2019
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Luis Paz-Ares, Reyes Bernabe Caro, et al.
Archivos De Bronconeumologia|December 30, 2023
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer PatientsCristina Candal-Pedreira, Alberto Ruano-Ravina, Virginia Calvo de Juan, et al.
The New England Journal of Medicine|April 21, 2015
Pembrolizumab for the treatment of non-small-cell lung cancerEdward B Garon, Naiyer A Rizvi, Rina Hui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2019
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF TrialMiguel-Angel Molina-Vila, Rolf A Stahel, Urania Dafni, et al.
BMC Cancer|September 1, 2021
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life dataLourdes Gutiérrez, Ana Royuela, Enric Carcereny, et al.
Pageof 11